Janise Chevrier-Lee
Vyloy Global Medical Affairs Lead, International Markets, MA Global Brand Strategy Astellas Pharma
Seminars
Thursday 13th November 2025
Panel Discussion: Establishing Scalable & Validated Digital Pathology to Support Patient Selection for ADC Therapies
10:30 am
- Establishing robust validity for digital pathology platforms to ensure reproducibility and accuracy across different laboratories
- What is the regulatory pathway for approving digital pathology based CDx approaches in APAC?
- Designing digital pathology networks to address pathologist shortages and ensure equitable diagnostic access in geographically dispersed APAC regions
